Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657849 · ClinicalTrials.gov registry record · NA
Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
A NA study of Enlarged Lymph Nodes (Excluding Infective), sponsored by HealthPartners Institute.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT03657849: Completed NA study of Enlarged Lymph Nodes (Excluding Infective), sponsored by HealthPartners Institute.
NCT03657849 is a NA study of Enlarged Lymph Nodes (Excluding Infective) that has completed, run by HealthPartners Institute. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03657849, a NA study of Enlarged Lymph Nodes (Excluding Infective), has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.
Primary Outcome
Diagnostic yield refers to the proportion of tissue samples collected by each needle (19 gauge vs 21 gauge) that were of sufficient quantity and quality to yield (i.e. produce) an accurate diagnosis for the patient's enlarged lymph nodes. Characterization of diagnostic category (true positive, true negative, false negative, false positive) were made by comparing the patient's presumed diagnosis/initial indication for presentation in comparison to their final diagnosis as determined by a combinat
Conditions Studied
Interventions
- DEVICE EBUS TBNA
Study Locations (1)
Minnesota
- Regions Hospital - Saint Paul
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-07-18 |
| Est. Completion | 2019-08-31 |
| Phase | NA |
What the finished NCT03657849 record still lists
NCT03657849 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Enlarged Lymph Nodes (Excluding Infective) appearing as the primary indexed condition, and to 1 intervention - of which EBUS TBNA is the first listed.
NCT03657849 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03657849 about?
NCT03657849 is a clinical study titled "Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy". This study compares the yield of 19-gauge needles vs 21-gauge needles during EBUS TBNA procedures.
What is the current status of trial NCT03657849?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2018-07-18. Estimated completion is 2019-08-31.
What conditions does trial NCT03657849 study?
This clinical trial studies the following conditions: Enlarged Lymph Nodes (Excluding Infective).
What interventions are being tested in trial NCT03657849?
The interventions under investigation include: EBUS TBNA (DEVICE).
Who is sponsoring clinical trial NCT03657849?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03657849 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03657849's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI